aTyr Pharma, Inc(NASDAQ:LIFE) 
aTyr Pharma, Inc., a clinical stage biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead clinical product candidate is ATYR1923, a selective modulator of NRP2 for the treatment of patients with s...
Website: http://www.atyrpharma.com
Founded: 2005
Full Time Employees: 39
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-12-05
P
O 1.26
H 1.30
L 1.23
C 1.25
V 138,322
10EMA 1.25
20EMA 1.25
60EMA 1.25
120EMA 1.25
250EMA 1.25